AAAAAA

   
Results: 1-14 |
Results: 14
ALTERNATING RADIOTHERAPY AND CHEMOTHERAPY IN LIMITED DISEASE SMALL-CELL LUNG-CANCER
Authors: LEPECHOUX C ARRIAGADA R LECHEVALIER T TARAYRE M RUFFIE P BALDEYROU P BRETEL JJ PELLAECOSSET B HANZEN C MARTIN M DUROUX P
Citation: C. Lepechoux et al., ALTERNATING RADIOTHERAPY AND CHEMOTHERAPY IN LIMITED DISEASE SMALL-CELL LUNG-CANCER, Radiotherapy and oncology, 46(3), 1998, pp. 257-261
A PHASE-II TRIAL OF RADIOCHEMOTHERAPY WITH DAILY CARBOPLATIN, AFTER INDUCTION CHEMOTHERAPY (CARBOPLATIN AND ETOPOSIDE), IN LOCALLY ADVANCEDNONSMALL-CELL LUNG-CANCER - FINAL ANALYSIS
Authors: BARDET E RIVIERE A CHARLOUX A SPAETH D DUCOLONE A LEGROUMELLEC A PELLAECOSSET B HENRYAMAR M DOUILLARD JY
Citation: E. Bardet et al., A PHASE-II TRIAL OF RADIOCHEMOTHERAPY WITH DAILY CARBOPLATIN, AFTER INDUCTION CHEMOTHERAPY (CARBOPLATIN AND ETOPOSIDE), IN LOCALLY ADVANCEDNONSMALL-CELL LUNG-CANCER - FINAL ANALYSIS, International journal of radiation oncology, biology, physics, 38(1), 1997, pp. 163-168
PHASE-I STUDIES OF COMBINED PACLITAXEL EPIRUBICIN AND PACLITAXEL/EPIRUBICIN/CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST-CANCER - THE FRENCH EXPERIENCE/
Authors: CATIMEL G SPIELMANN M DIERAS V TUBIANAHULIN M BONNETERRE J POUILLART P KAYITALIRE L GUASTALLA JP GRAFFAND N GARET F DUMORTIER A PELLAECOSSET B
Citation: G. Catimel et al., PHASE-I STUDIES OF COMBINED PACLITAXEL EPIRUBICIN AND PACLITAXEL/EPIRUBICIN/CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST-CANCER - THE FRENCH EXPERIENCE/, Seminars in oncology, 24(1), 1997, pp. 8-12
PHASE-I STUDY OF PACLITAXEL AND EPIRUBICIN IN PATIENTS WITH METASTATIC BREAST-CANCER - A PRELIMINARY-REPORT ON SAFETY
Authors: CATIMEL G SPIELMANN M DIERAS V KAYITALIRE L POUILLART P GUASTALLA JP SOLERMICHEL P GRAFFAND N GARET F DUMORTIER A PELLAECOSSET B CHAZARD M
Citation: G. Catimel et al., PHASE-I STUDY OF PACLITAXEL AND EPIRUBICIN IN PATIENTS WITH METASTATIC BREAST-CANCER - A PRELIMINARY-REPORT ON SAFETY, Seminars in oncology, 23(1), 1996, pp. 24-27
TAXOL(R) (PACLITAXEL) 225 MG M(2) BY 3-HOUR INFUSION WITHOUT G-CSF ASA FIRST LINE THERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER (MBC)/
Authors: BONNETERRE J TUBIANAHULIN M CHOLLET P CHEVALLIER B FUMOLEAU P KERBRAT P VIE B KHAYAT D TUBIANA N LEJEUNE C LEGRAND A SOARES JA PELLAECOSSET B
Citation: J. Bonneterre et al., TAXOL(R) (PACLITAXEL) 225 MG M(2) BY 3-HOUR INFUSION WITHOUT G-CSF ASA FIRST LINE THERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER (MBC)/, European journal of cancer, 31A, 1995, pp. 354-354
TAXOL(R) (PACLITAXEL) AND FARMORUBICIN(R) (EPIRUBICIN) IN METASTATIC BREAST-CANCER (MBC) - PRELIMINARY-RESULTS OF A PHASE-I STUDY
Authors: SPIELMANN M CATIMEL G KAYITALIRE L POUILLART P DUMORTIER A GRAFFAND N PELLAECOSSET B
Citation: M. Spielmann et al., TAXOL(R) (PACLITAXEL) AND FARMORUBICIN(R) (EPIRUBICIN) IN METASTATIC BREAST-CANCER (MBC) - PRELIMINARY-RESULTS OF A PHASE-I STUDY, European journal of cancer, 31A, 1995, pp. 370-370
A PHASE-II STUDY OF TAXOL(R) (T) (PACLITAXEL) OVER 3 HOURS (H) IN 192PLATINUM PRETREATED PATIENTS (PTS) FOR OVARIAN-CARCINOMA (OC)
Authors: LHOMME C GUASTALLA JP DAUPLAT J FERRERO JM OBERLING F VENNIN P POUILLART P FUMOLEAU P KERBRAT P TUBIANA N HERON JF BUGAT R BACHELOT T SCHREINEROVA M FLEURY J NAMER M DUFOUR P DIERAS V SOLARMICHEL P PRUVOT I CHANEZ MA GARET F CHAZARD M PELLAECOSSET B
Citation: C. Lhomme et al., A PHASE-II STUDY OF TAXOL(R) (T) (PACLITAXEL) OVER 3 HOURS (H) IN 192PLATINUM PRETREATED PATIENTS (PTS) FOR OVARIAN-CARCINOMA (OC), European journal of cancer, 31A, 1995, pp. 507-507
PHASE I II STUDY OF PACLITAXEL PLUS CISPLATIN AS FIRST-LINE CHEMOTHERAPY FOR ADVANCED NON-SMALL-CELL LUNG-CANCER - PRELIMINARY-RESULTS/
Authors: BELLI L LECHEVALIER T GOTTFRIED M ADAMS D RUFFLE P LECESNE A TETE L PELLAECOSSET B
Citation: L. Belli et al., PHASE I II STUDY OF PACLITAXEL PLUS CISPLATIN AS FIRST-LINE CHEMOTHERAPY FOR ADVANCED NON-SMALL-CELL LUNG-CANCER - PRELIMINARY-RESULTS/, Seminars in oncology, 22(6), 1995, pp. 29-33
LOCAL RELAPSE AND CONTRALATERAL TUMOR RATES IN PATIENTS WITH BREAST-CANCER TREATED WITH CONSERVATIVE SURGERY AND RADIOTHERAPY (INSTITUT-GUSTAVE-ROUSSY 1970-1982)
Authors: DEWAR JA ARRIAGADA R BENHAMOU S BENHAMOU E BRETEL JJ PELLAECOSSET B MARIN JL PETIT JY CONTESSO G SARRAZIN D
Citation: Ja. Dewar et al., LOCAL RELAPSE AND CONTRALATERAL TUMOR RATES IN PATIENTS WITH BREAST-CANCER TREATED WITH CONSERVATIVE SURGERY AND RADIOTHERAPY (INSTITUT-GUSTAVE-ROUSSY 1970-1982), Cancer, 76(11), 1995, pp. 2260-2265
CARBOPLATIN AND UROTHELIAL TUMORS - AN OV ERVIEW
Authors: AUSELO NM BONSROSSET F PELLAECOSSET B COSTA P SCHWARTZ Y LOUIS JF NAVRATIL H
Citation: Nm. Auselo et al., CARBOPLATIN AND UROTHELIAL TUMORS - AN OV ERVIEW, Bulletin du cancer, 82(3), 1995, pp. 181-188
PHASE-I STUDY OF CARBOPLATIN IN ASSOCIATION WITH CYTARABIN OR VP16 INTHE TREATMENT OF POOR-RISK ACUTE-LEUKEMIA
Authors: STOPPA AM MUNCK JN JOURDAN E BOUABDALLAH R BOULET JM ROSSI JF PICO J GASTAUT JA PELLAECOSSET B BLAISE D MARANINCHI D
Citation: Am. Stoppa et al., PHASE-I STUDY OF CARBOPLATIN IN ASSOCIATION WITH CYTARABIN OR VP16 INTHE TREATMENT OF POOR-RISK ACUTE-LEUKEMIA, Blood, 86(10), 1995, pp. 3117-3117
TAXOL (PACLITAXEL), 1ST MOLECULE OF A NEW CLASS OF CYTOTOXIC AGENTS -TAXANES
Authors: CHAZARD M PELLAECOSSET B GARET F SOARES JA LUCIDI B LAVAIL Y LENAZ L
Citation: M. Chazard et al., TAXOL (PACLITAXEL), 1ST MOLECULE OF A NEW CLASS OF CYTOTOXIC AGENTS -TAXANES, Bulletin du cancer, 81(3), 1994, pp. 173-181
NEOADJUVANT CHEMOTHERAPY WITH CARBOPLATIN 5-FLUOROURACIL IN HEAD AND NECK-CANCER
Authors: DEPONDT J GEHANNO P MARTIN M LELIEVRE G GUERRIER B PEYTRAL C SCHOTT H PELLAECOSSET B
Citation: J. Depondt et al., NEOADJUVANT CHEMOTHERAPY WITH CARBOPLATIN 5-FLUOROURACIL IN HEAD AND NECK-CANCER, Oncology, 50, 1993, pp. 23-27
PLATINUM COMPOUNDS IN PEDIATRIC ONCOLOGY
Authors: DOZ F PINKERTON R PACQUEMENT H MICHON J QUINTANA E BASTIAN G CHAZARD M PELLAECOSSET B ZUCKER JM
Citation: F. Doz et al., PLATINUM COMPOUNDS IN PEDIATRIC ONCOLOGY, Archives francaises de pediatrie, 50(4), 1993, pp. 353-359
Risultati: 1-14 |